Back to Search Start Over

Virtual ablation for atrial fibrillation in personalized in-silico three-dimensional left atrial modeling: Comparison with clinical catheter ablation.

Authors :
Hwang, Minki
Kwon, Soon-Sung
Wi, Jin
Park, Mijin
Lee, Hyun-Seung
Park, Jin-Seo
Lee, Young-Seon
Shim, Eun Bo
Pak, Hui-Nam
Source :
Progress in Biophysics & Molecular Biology. Sep2014, Vol. 116 Issue 1, p40-47. 8p.
Publication Year :
2014

Abstract

Background Although catheter ablation is an effective rhythm control strategy for atrial fibrillation (AF), empirically-based ablation has a substantial recurrence rate. The purposes of this study were to develop a computational platform for patient-specific virtual AF ablation and to compare the anti-fibrillatory effects of 5 different virtual ablation protocols with empirically chosen clinical ablations. Methods We included 20 patients with AF (65% male, 60.1 ± 10.5 years old, 80% persistent AF [PeAF]) who had undergone empirically-based catheter ablation: circumferential pulmonary vein isolation (CPVI) for paroxysmal AF (PAF) and additional posterior box lesion (L1) and anterior line (L2) for PeAF. Using patient-specific three-dimensional left atrial (LA) geometry, we generated a finite element model and tested the AF termination rate after 5 different virtual ablations: CPVI alone, CPVI + L1, CPVI + L1,2, CPVI with complex fractionated atrial electrogram (CFAE) ablation, and CFAE ablation alone. Results 1. Virtual CPVI + L1,2 ablation showed the highest AF termination rate in overall patients (55%) and PeAF patients ( n = 16, 62.5%). 2. The virtual AF maintenance duration was shortest in the case of virtual CPVI + L1,2 ablation in overall patients (2.19 ± 1.28 vs. 2.91 ± 1.04 s, p = 0.009) and in patients with PeAF (2.05 ± 1.23 vs. 2.93 ± 10.2 s, p = 0.004) compared with other protocols. Conclusion Virtual AF ablation using personalized in-silico model of LA is feasible. Virtual ablation with CPVI + L1,2 shows the highest antifibrillatory effect, concordant with the empirical ablation protocol in patients with PeAF. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00796107
Volume :
116
Issue :
1
Database :
Academic Search Index
Journal :
Progress in Biophysics & Molecular Biology
Publication Type :
Academic Journal
Accession number :
99512027
Full Text :
https://doi.org/10.1016/j.pbiomolbio.2014.09.006